Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

Predictors of local adverse effects caused by topical tretinoin cream 0·1% in the Veterans Affairs Topical Tretinoin Chemoprevention trial.

Pomerantz H, Weinstock MA; Veterans Affairs Topical Tretinoin Chemoprevention (VATTC) Group.

Br J Dermatol. 2014 Sep;171(3):642-5. doi: 10.1111/bjd.12987. Epub 2014 Jul 23.

PMID:
24666361
2.

Fluorouracil and other predictors of morpheaform basal cell carcinoma among high-risk patients: the Veterans Affairs Topical Tretinoin Chemoprevention Trial.

Xiong MY, Korgavkar K, Digiovanna JJ, Weinstock MA; Veterans Affairs Topical Tretinoin Chemoprevention Trial Group.

JAMA Dermatol. 2014 Mar;150(3):332-4. doi: 10.1001/jamadermatol.2013.5619. No abstract available.

PMID:
24258386
3.

Periocular actinic keratosis, keratinocyte carcinomas, and eyeglasses use.

Lee KC, Weinstock MA; Department of Veterans Affairs Topical Tretinoin Chemoprevention Trial Group.

J Am Acad Dermatol. 2013 Jul;69(1):165-7. doi: 10.1016/j.jaad.2013.02.015. No abstract available.

PMID:
23768294
4.

Predictors of squamous cell carcinoma in high-risk patients in the VATTC trial.

Xiong MY, Rizzo AE, Cohen TS, Dyer RK, Korgavkar K, Bingham SF, Weinstock MA; Veterans Affairs Topical Tretinoin Chemoprevention(VATTC) Trial Group.

J Invest Dermatol. 2013 Jun;133(6):1521-32. doi: 10.1038/jid.2013.35. Epub 2013 Feb 24.

5.

Gas-phase synthesis of the silaisocyanoethylene molecule (C2H3NSi).

Parker DS, Wilson AV, Kaiser RI, Labrador T, Mebel AM.

J Org Chem. 2012 Oct 5;77(19):8574-80. doi: 10.1021/jo3015402. Epub 2012 Sep 25.

PMID:
22954358
6.

Synthesis of the silaisocyanoacetylene molecule.

Parker DS, Wilson AV, Kaiser RI, Labrador T, Mebel AM.

J Am Chem Soc. 2012 Aug 22;134(33):13896-901. doi: 10.1021/ja305569k. Epub 2012 Aug 10.

PMID:
22856647
7.

Predictors of basal cell carcinoma in high-risk patients in the VATTC (VA Topical Tretinoin Chemoprevention) trial.

Dyer RK, Weinstock MA, Cohen TS, Rizzo AE, Bingham SF; VATTC Trial Group.

J Invest Dermatol. 2012 Nov;132(11):2544-51. doi: 10.1038/jid.2012.227. Epub 2012 Jul 19.

8.

Tretinoin and the prevention of keratinocyte carcinoma (Basal and squamous cell carcinoma of the skin): a veterans affairs randomized chemoprevention trial.

Weinstock MA, Bingham SF, Digiovanna JJ, Rizzo AE, Marcolivio K, Hall R, Eilers D, Naylor M, Kirsner R, Kalivas J, Cole G, Vertrees JE; Veterans Affairs Topical Tretinoin Chemoprevention Trial Group.

J Invest Dermatol. 2012 Jun;132(6):1583-90. doi: 10.1038/jid.2011.483. Epub 2012 Feb 9.

9.

Association between non-steroidal anti-inflammatory drugs and keratinocyte carcinomas of the skin among participants in the Veterans Affairs Topical Tretinoin Chemoprevention Trial.

Nunes AP, Lapane KL, Weinstock MA; VATTC Trial Group.

Pharmacoepidemiol Drug Saf. 2011 Sep;20(9):922-9. doi: 10.1002/pds.2142. Epub 2011 Jun 18.

PMID:
21688346
10.

Prospective quality of life impact of keratinocyte carcinomas: observations from the Veterans Affairs Topical Tretinoin Chemoprevention Trial.

Lee KC, Weinstock MA; Veterans Affairs Topical Tretinoin Chemoprevention (VATTC) Trial Group.

J Am Acad Dermatol. 2010 Dec;63(6):1107-9. doi: 10.1016/j.jaad.2010.02.014. No abstract available.

PMID:
21093671
11.

Tolerability of high-dose topical tretinoin: the Veterans Affairs Topical Tretinoin Chemoprevention Trial.

Geng A, Weinstock MA, Hall R, Eilers D, Naylor M, Kalivas J; VATTC Trial Group.

Br J Dermatol. 2009 Oct;161(4):918-24. doi: 10.1111/j.1365-2133.2009.09341.x. Epub 2009 Jun 11.

PMID:
19681859
12.

Quality of life in the actinic neoplasia syndrome: The VA Topical Tretinoin Chemoprevention (VATTC) Trial.

Weinstock MA, Lee KC, Chren MM, Marcolivio K; VATTC Trial Group.

J Am Acad Dermatol. 2009 Aug;61(2):207-15. doi: 10.1016/j.jaad.2009.02.022. Epub 2009 Apr 26.

13.

Actinic keratoses: Natural history and risk of malignant transformation in the Veterans Affairs Topical Tretinoin Chemoprevention Trial.

Criscione VD, Weinstock MA, Naylor MF, Luque C, Eide MJ, Bingham SF; Department of Veteran Affairs Topical Tretinoin Chemoprevention Trial Group.

Cancer. 2009 Jun 1;115(11):2523-30. doi: 10.1002/cncr.24284.

14.

Association of ACE inhibitors and angiotensin receptor blockers with keratinocyte cancer prevention in the randomized VATTC trial.

Christian JB, Lapane KL, Hume AL, Eaton CB, Weinstock MA; VATTC Trial.

J Natl Cancer Inst. 2008 Sep 3;100(17):1223-32. doi: 10.1093/jnci/djn262. Epub 2008 Aug 26.

PMID:
18728281
15.

Levofloxacin versus ceftriaxone plus clarithromycin in the treatment of adults with community-acquired pneumonia requiring hospitalization.

Querol-Ribelles JM, Tenías JM, Querol-Borrás JM, Labrador T, Nieto A, González-Granda D, Martínez I.

Int J Antimicrob Agents. 2005 Jan;25(1):75-83.

PMID:
15620830
16.
17.

Transvaginal sonography in endometrial carcinoma: preoperative assessment of the depth of myometrial invasion in 50 cases.

Olaya FJ, Dualde D, García E, Vidal P, Labrador T, Martínez F, Gordo G.

Eur J Radiol. 1998 Feb;26(3):274-9.

PMID:
9587755
18.

[Chronic polyarthritis].

Querol JM, Gómez A, Alonso MC, Lamberto Climent J, Labrador T.

Enferm Infecc Microbiol Clin. 1993 Jun-Jul;11(6):335-6. Spanish. No abstract available.

PMID:
8347706
19.

[Usefulness of IgG and IgM detection against antigen 60 in the diagnosis of thoracic tuberculosis].

Querol JM, Oltra C, Granda D, Alonso MC, Climent JL, Labrador T, Mínguez J.

An Med Interna. 1993 Jun;10(6):271-4. Spanish.

PMID:
8334203

Supplemental Content

Loading ...
Support Center